The disruption of Reelin signaling has been recently recognized as a pathological mechanism in AD, as the Reelin–ApoER2/VLDLR pathway regulates tau phosphorylation and amyloid-β metabolism in AD [1,20]. Here, MAPT is linked to Alzheimer disease.